Terms: = Germ cell tumor AND SEPT5, HCDCREL-1, 5413, ENSG00000184702, Q99719, PNUTL1, H5
15 results:
1. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study.
Mandair D; Kamieniarz L; Pizanias M; Weickert MO; Narayan A; O'Mahony LF; Caplin M; Ramage J; Prachalias A; Srirajaskanthan R; Toumpanakis C
Sci Rep; 2022 Sep; 12(1):15762. PubMed ID: 36130981
[TBL] [Abstract] [Full Text] [Related]
2. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
[TBL] [Abstract] [Full Text] [Related]
3. Investigations into the potential anticancer activity of Maximin H5.
Dennison SR; Harris F; Phoenix DA
Biochimie; 2017 Jun; 137():29-34. PubMed ID: 28249727
[TBL] [Abstract] [Full Text] [Related]
4. Expression profile of parkin isoforms in human gliomas.
Maugeri G; D'Amico AG; Magro G; Salvatorelli L; Barbagallo GM; Saccone S; Drago F; Cavallaro S; D'Agata V
Int J Oncol; 2015 Oct; 47(4):1282-92. PubMed ID: 26238155
[TBL] [Abstract] [Full Text] [Related]
5. Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.
Kuan CT; Wikstrand CJ; McLendon RE; Zalutsky MR; Kumar U; Bigner DD
Hybridoma (Larchmt); 2009 Dec; 28(6):389-403. PubMed ID: 20025498
[TBL] [Abstract] [Full Text] [Related]
6. Risk associations of melanoma in a Southern European population: results of a case/control study.
Nikolaou VA; Sypsa V; Stefanaki I; Gogas H; Papadopoulos O; Polydorou D; Plaka M; Tsoutsos D; Dimou A; Mourtzoukou E; Korfitis V; Hatziolou E; Antoniou C; Hatzakis A; Katsambas A; Stratigos AJ
Cancer Causes Control; 2008 Sep; 19(7):671-9. PubMed ID: 18307049
[TBL] [Abstract] [Full Text] [Related]
7. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
Cho H; Kim WJ; Lee YM; Kim YM; Kwon YG; Park YS; Choi EY; Kim KW
Oncol Rep; 2004 Jan; 11(1):191-5. PubMed ID: 14654925
[TBL] [Abstract] [Full Text] [Related]
8. Identification and functional validation of a 5' upstream regulatory sequence in the human tyrosinase gene homologous to the locus control region of the mouse tyrosinase gene.
Regales L; Giraldo P; García-Díaz A; Lavado A; Montoliu L
Pigment Cell Res; 2003 Dec; 16(6):685-92. PubMed ID: 14629727
[TBL] [Abstract] [Full Text] [Related]
9. sept5_v2 is a parkin-binding protein.
Choi P; Snyder H; Petrucelli L; Theisler C; Chong M; Zhang Y; Lim K; Chung KK; Kehoe K; D'Adamio L; Lee JM; Cochran E; Bowser R; Dawson TM; Wolozin B
Brain Res Mol Brain Res; 2003 Oct; 117(2):179-89. PubMed ID: 14559152
[TBL] [Abstract] [Full Text] [Related]
10. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
[TBL] [Abstract] [Full Text] [Related]
11. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
[TBL] [Abstract] [Full Text] [Related]
12. Comet assay study of DNA damage and repair of tumour cells following boron neutron capture irradiation with fast d(14) + Be neutrons.
Pöller F; Bauch T; Sauerwein W; Böcker W; Wittig A; Streffer C
Int J Radiat Biol; 1996 Nov; 70(5):593-602. PubMed ID: 8947541
[TBL] [Abstract] [Full Text] [Related]
13. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract] [Full Text] [Related]
14. [Stereotaxic laser interstitial thermotherapy. A new alternative in the therapeutic management of some brain tumors].
Roux FX; Merienne L; Fallet-Bianco C; Beuvon F; Devaux B; Leriche B; Cioloca C
Neurochirurgie; 1992; 38(4):238-44. PubMed ID: 1300460
[TBL] [Abstract] [Full Text] [Related]
15. Rapid estimation of the proliferating index of brain tumours.
Detta A; Hitchcock E
J Neurooncol; 1990 Jun; 8(3):245-53. PubMed ID: 2358856
[TBL] [Abstract] [Full Text] [Related]
